Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04911374 · ClinicalTrials.gov registry record · NA

An Open-Label Clinical Study to Evaluate the Efficacy of a Face Cream and Eye Cream

A NA study of Wrinkle and Photoaging, sponsored by Revision Skincare.

Completed
Registry status
NA
Development phase
45
Enrollment target
1
Study location

NCT04911374 is a NA study of Wrinkle and Photoaging that has completed, run by Revision Skincare. The registered enrollment target is 45 participants, below the 118-participant average among 25 other Wrinkle trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04911374, a NA study of Wrinkle and Photoaging, has completed, sponsored by Revision Skincare.

COMPLETED
Registry status
NA
Development phase
45 participants
Enrollment target
1
Study location

Study Summary

This single-center clinical trial is being conducted to assess the efficacy and tolerability of an anti-aging eye cream and face moisturizer when used over the course of 12 weeks twice-daily by women, 35-65 years, with mild to moderate droopy eyelids, moderate crow's feet wrinkles, and moderate global facial photodamage.

Interventions

  • OTHER Gentle Cleansing Lotion, Revision Skincare
  • OTHER Aveeno Face Milk SPF 40+

Study Locations (1)

Texas

  • Stephens and Associates - Richardson

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2020-09-11
Est. Completion 2021-02-03
Phase NA

Sponsor

Revision Skincare

18 total trials

What the Registry Record Tells You About NCT04911374

The ClinicalTrials.gov registry entry for NCT04911374 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 118-participant average among 25 other Wrinkle trials with a reported enrollment target (62% lower). The listed sponsor is Revision Skincare, which has 18 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Wrinkle appearing as the primary indexed condition, and to 2 interventions - of which Gentle Cleansing Lotion, Revision Skincare is the first listed.

NCT04911374 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT04911374 about?

NCT04911374 is a clinical study titled "An Open-Label Clinical Study to Evaluate the Efficacy of a Face Cream and Eye Cream". This single-center clinical trial is being conducted to assess the efficacy and tolerability of an anti-aging eye cream and face moisturizer when used over the course of 12 weeks twice-daily by women, 35-65 years, with mild to moderate droopy eyelids, moderate crow's feet wrinkles, and moderate glob...

What is the current status of trial NCT04911374?

This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2020-09-11. Estimated completion is 2021-02-03.

What conditions does trial NCT04911374 study?

This clinical trial studies the following conditions: Wrinkle, Photoaging, Fine Lines.

What interventions are being tested in trial NCT04911374?

The interventions under investigation include: Gentle Cleansing Lotion, Revision Skincare (OTHER), Aveeno Face Milk SPF 40+ (OTHER).

Who is sponsoring clinical trial NCT04911374?

This trial is sponsored by Revision Skincare, which has 18 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04911374 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Wrinkle

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.